JHSNSEJHS Svendgaard Laboratories Limited· Personal CareMinimalNeutral
Announced Mon, 22 Sept · 15:10 IST

JHS Svendgaard Laboratories Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 20, 2025

JHS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

JHS Svendgaard Laboratories Limited held its 21st Annual General Meeting on September 20, 2025 via video conferencing. All 7 resolutions were passed with overwhelming majority, including adoption of standalone and consolidated financial statements for FY2024-25, appointment of statutory and secretarial auditors, re-appointment of Mr. Vinay Mittal as director and Mr. Nikhil Nanda as Managing Director, and approval of the Employee Stock Option Scheme 2025. Out of 25,671 shareholders on record date, 89 members cast their votes, with 3 promoter group members and 86 public shareholders attending via video conferencing. Most resolutions received 99.99% assent, except the Managing Director re-appointment which got 99.76% approval (with 3,065,985 votes recorded as invalid).

Likely market impact

The near-unanimous approval of all resolutions signals strong shareholder support for the company's direction. The ESOP 2025 approval may lead to equity dilution in the future but is aimed at employee retention. Re-appointment of Mr. Nikhil Nanda as Managing Director ensures management continuity.